Stock Price
0.40
Daily Change
-0.01 -2.44%
Monthly
8.11%
Yearly
280.95%
Q1 Forecast
0.37

Starpharma Holdings reported AUD-4.85M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -17.78M 17.03M Jun/2025
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024